Peramivir
A neuraminidase inhibitor used as a single-dose intravenous treatment for uncomplicated influenza in adults and children, particularly when oral agents cannot be used. It blocks the influenza neuraminidase enzyme, preventing new virus particles from being released from infected cells.
Molekularmasse
328,4100 g/mol
LogP
0,00
TPSA
151,00 Ų
Lipinski-Regel der Fünf
Bestanden
Wirkmechanismus
Inhibits viral neuraminidase, preventing the release of newly formed virus particles from infected cells and limiting viral spread within the respiratory tract.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Inhibits viral neuraminidase, preventing the release of newly formed virus particles from infected cells and limiting viral spread within the respiratory tract.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N.O.O.O
InChI
InChI=1S/C15H28N4O4.3H2O/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23;;;/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19);3*1H2/t9-,10+,11+,12-,13+;;;/m0.../s1
Molecular Formula
C15H28N4O4
HBD / HBA
5 / 5
Rotierbare Bindungen
7
Schwere Atome
23
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
A neuraminidase inhibitor used as a single-dose intravenous treatment for uncomplicated influenza in adults and children, particularly when oral agents cannot be used. It blocks the influenza neuraminidase enzyme, preventing new virus particles from being released from infected cells.
Inhibits viral neuraminidase, preventing the release of newly formed virus particles from infected cells and limiting viral spread within the respiratory tract.
Yes, Peramivir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989402. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 154234. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="peramivir"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/peramivir/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/peramivir/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/peramivir/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="peramivir"></drugfyi-drug>